Ascorbate and Tocolysis - a phase IV clinical study of FDA data
Summary:
We study 2,265 people who take Ascorbate (vitamin c (ascorbic acid)) or have Tocolysis. No report of Tocolysis is found in people who take Ascorbate.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
What is Ascorbate?
Ascorbate has active ingredients of vitamin c (ascorbic acid). eHealthMe is studying from 1,446 Ascorbate users. Check the latest studies of Ascorbate.
What is Tocolysis?
Tocolysis (inhibition of uterine contractions) is found to be associated with 4 drugs and 25 conditions by eHealthMe. Check the latest studies of Tocolysis.
No report is found.
Do you take Ascorbate and have Tocolysis?
- Check whether Tocolysis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Ascorbate:
- Ascorbate (1,446 reports)
Tocolysis treatments and more:
- Tocolysis (819 reports)
How severe was Tocolysis and when was it recovered:
Expand to all the drugs that have ingredients of vitamin c (ascorbic acid):
Browse all side effects of Ascorbate:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Tocolysis:
Browse all the conditions that are associated with Tocolysis:
How the study uses the data?
The study uses data from the FDA. It is based on vitamin c (ascorbic acid) (the active ingredients of Ascorbate) and Ascorbate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Duphalac and Atrovent - 25 seconds ago
- Rashes and drugs of ingredients of octreotide acetate - 30 seconds ago
- Dutoprol vs. Asa, side effect and effectiveness comparison - 38 seconds ago
- Claritin-D and Multivitamin drug interactions for women aged 30-39 - 41 seconds ago
- Acne and drugs of ingredients of candesartan cilexetil - a minute ago
- Mineral Supplementation and Device Occlusion - a minute ago
- Could Multivitamin cause Vasodilatation? - a minute ago
- Malnutrition and drugs of ingredients of phytonadione - a minute ago
- Drug interactions of Strattera and Symbicort - a minute ago
- Prialt vs. Zanaflex, side effect and effectiveness comparison - 2 minutes ago